Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Leukemia Research|December 2, 2014
Isolated +15 in bone marrow: disease-associated or a benign finding?Rashmi Shivani Goswami, Cynthia S Liang, Carlos E Bueso-Ramos, et al.Leukemia Research|June 25, 2013
Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literatureBrady E Beltran, Pilar Quiñones, Domingo Morales, et al.Cancer Medicine|July 6, 2024
Impact of genomic and epigenomic alterations of multigene on a multicancer pedigreeJingyu Gao, Yongzhang Wu, Jieming Yu, et al.Clinical Lymphoma, Myeloma & Leukemia|June 2, 2015
Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q DeletionMeenakshi Mehrotra, Keyur P Patel, Tianjian Chen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of diseaseJesse M Jaso, C Cameron Yin, Victoria W Lu, et al.Cancer|November 1, 2011
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53Rashmi Kanagal-Shamanna, Carlos E Bueso-Ramos, Bedia Barkoh, et al.Leukemia & Lymphoma|March 12, 2014
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed diseaseLan V Pham, Muychi T Vang, Archito T Tamayo, et al.Archives of Pathology & Laboratory Medicine|May 1, 2013
Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasmsGary Lu, Ramya Muddasani, Robert Z Orlowski, et al.Leukemia & Lymphoma|June 14, 2012
Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemiaSergej Konoplev, C Cameron Yin, Steven M Kornblau, et al.Carcinogenesis|February 18, 2010
Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitroGuang-Xun Li, Yu-Kuo Chen, Zhe Hou, et al.Pageof 5